EMD
Asset Logo

Emyria Limited

πŸ‡¦πŸ‡Ί ASX

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

15
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Emyria Ltd. is a healthcare technology and services company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2020-02-12. The firm is focused on accelerating drug development and improving patient outcomes in neuroscience and mental health through its drug development, new drug discovery, and proprietary real-world data (RWD). The company applies in-house drug development expertise, and proprietary real-world evidence (RWE) gathered from its clinical service, to accelerate the development and registration of two biopharmaceutical drug classes: Ultra-Pure cannabidiol-based medical treatments (CBMTs) and MDMA (ecstasy) analogues. Its CBMT development program leverages the proprietary RWE to identify specific dose responses, for specific indications, in specific patient populations. Its EMD-RX5 is a novel, capsule formulation of Ultra-Pure, synthetic cannabidiol to support its registration as an over-the-counter treatment for mild stress and anxiety in patients with chronic pain. The company is also advancing Ultra-Pure CBD (EMD-RX7).

πŸ“ˆ Performance

Price History

-30.00%

1M

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.14

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in EMD

15

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in EMD

699 days
EMD investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

18%

50k - 100k

47%

Less than 50k

35%
πŸ‘Ά Age of investors

18 - 25

26 - 34

20%

35 - 90

73%
πŸ™‹ Legal gender of investors

Female

73%

Male

27%

Pearlers who invest in EMD also invest in...

VDHG

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

πŸ“Š Share price

$57.36 AUD

NULL GLOBAL

NULL SMART BETA

Find Out More

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ“Š Share price

$104.08 AUD

NULL GLOBAL

NULL EX AUSTRALIA

NULL BETA

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ“Š Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

πŸ“Š Share price

$120.79 AUD

NULL AUSTRALIA

NULL BETA

Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The firm has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The firm focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.

πŸ“Š Share price

$0.17 AUD

Want more shares? Try these...

Energy Metals Ltd. is an Australian uranium exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2005-09-09. The firm is focused on exploration and development of a portfolio of projects located in the Northern Territory and Western Australia. The firm has eight projects covering an area of 2,400 square kilometers (km2). Its projects include Bigrlyi, Ngalia regional, Macallan, Anketell, Mopoke Well, Lakeside, Manyingee and Lake Mason. The Bigrlyi deposit is a sandstone hosted uranium-vanadium deposit located on the northern margin of the Ngalia Basin, approximately 350 kilometer (km) northwest of Alice Springs. The Ngalia Regional project is located in the Ngalia Basin, between 180 and 350 km northwest of Alice Springs in the Northern Territory. The Macallan project comprises single exploration license application (ELA27333), located approximately 460 km northwest of Alice Springs and 140 km from Bigrlyi. The Anketell project is located approximately 100 km east of Mt Magnet and comprises retention license R58/2.

πŸ“Š Share price

$0.10 AUD

πŸ“Š Share price

$0.00 AUD
Compare
Add to watchlist